Evogene Ltd. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ALDX
|
Aldeyra Therapeutics, Inc. | $5.35 | $229.34 M | -7.57 | 10 | $0 |
 BDRX
|
Biodexa Pharmaceuticals Plc | $5.47 | $222,107 | -0.09 | 21 | $381,000 |
 CANF
|
Can-Fite BioPharma Ltd. | $1.97 | $11.71 M | -0.82 | 8 | $743,000 |
 CGEN
|
Compugen Ltd. | $1.84 | $188.91 M | -11.72 | 68 | $33.46 M |
 CKPT
|
Checkpoint Therapeutics, Inc. | $2.22 | $68.32 M | -0.72 | 23 | $103,000 |
 CLGN
|
CollPlant Biotechnologies Ltd. | $4.81 | $58.76 M | -7.77 | 75 | $10.96 M |
 CRVS
|
Corvus Pharmaceuticals, Inc. | $5.62 | $126.98 M | -3.98 | 28 | $0 |
 FATE
|
Fate Therapeutics, Inc. | $3.23 | $418.90 M | -1.92 | 181 | $63.53 M |
 GMDA
|
Gamida Cell Ltd. | $0.03 | $4.34 M | -0.04 | 143 | $1.78 M |
 ICCC
|
ImmuCell Corporation | $3.66 | $35.08 M | -8.8 | 75 | $17.47 M |
 LEXX
|
Lexaria Bioscience Corp. | $3.20 | $46.84 M | -4.88 | 5 | $226,208 |
 NAVB
|
Navidea Biopharmaceuticals, Inc. | $0.00 | $10,008 | 0 | 11 | $65,652 |
 ONCR
|
Oncorus, Inc. | $0.12 | $3.29 M | -0.04 | 64 | $0 |
 PLUR
|
Pluri Inc. | $5.19 | $31.25 M | -1.41 | 106 | $326,000 |
 PLX
|
Protalix BioTherapeutics, Inc. | $1.05 | $82.11 M | 14 | 208 | $65.49 M |
 RCUS
|
Arcus Biosciences, Inc. | $16.64 | $1.41 B | -4.98 | 577 | $117.00 M |
 SURF
|
Surface Oncology, Inc. | $1.07 | $65.08 M | -0.69 | 35 | $30.00 M |
 ZVSA
|
ZyVersa Therapeutics, Inc. | $2.22 | $3.68 M | 0 | 7 | $0 |